COVID-19 Vaccine: WHO approves two versions of Oxford-Astrazeneca for emergency use

The World Health Organization, (WHO), has approved two versions of the Oxford-Astrazeneca COVID-19 vaccine for emergency use, clearing the way for the vaccines to be shipped to African countries through the Covax scheme.

Covax is a global initiative in which countries pool their resources to support the development of vaccines with a view to ensure that all countries receive a fair supply of effective vaccines.

The vaccine has been found to have 63.09 percent efficacy and is suitable for low and middle-income countries due to easy storage requirements.

A group of experts on immunisation assembled by who recommended the vaccine for all age groups above 18 years.